ABSTRACT
Purpose of the study: During the emergency period Covid-19 the glycosilate hemoglobin has been required for patients admitted to specialist wards suitable for metabolic control in diabetics and non-diabetics. Material and methods: The test HbA1c has been performed on Variant II Biorad, calibrated with standard Biorad for glycate hemoglobin, using EDTA whole blood samples after running two-tier Biorad controls. Results: The patients have been studied in the wave of coronavirus infection corresponding to the two months of loackdown. Thirty patients that have been hospitalized in covid area have been tested in our laboratory . In 12 females and 6 males with average age 50 years old the HbA1c has been resulted in the limits (up to 42 mmoli/moles) and in 10 patients ( 6 females and 4 males average age 48 years old ) higher values ( between 51 and 79 mmoli/molioli ) have been found. The patients have been so followed for the care of the case. Discussion and conclusion: Thus it has been possible to discern among patients with comorbidity and patients with lower degree of exposure to risks because in return to metabolic improvement and it has been possible to collaborate for the health of the sicks.